Board of Directors
Jeffrey M. Folick is Chairman & CEO of Bravo Health, Inc.
Michael E. Aspinwall is a Managing Partner at CCP Equity Partners. His current board memberships include: Vantage Oncology, Inc., Evolution Benefits, Inc. and Kadent Inc.
Edmund Bujalski is President & CEO of Bariatric Partners, Inc., a national health care company. He began his career more than 30 years ago as a consultant with the Boston Consulting Group.
Scott Gottlieb, M.D. is an expert in health care policy and spent three years as a Venture Partner at New Enterprise Associates. Dr. Gottlieb also served as the Deputy Commissioner of the Food and Drug Administration and as a Senior Policy Advisor to the Administrator of the Centers for Medicare and Medicaid Services. He currently serves on the boards of MedaVante, Combimatrix, and Molecular Insight.
Tom Hodge is a General Partner at Frazier Healthcare Ventures. He has over 25 years of experience working with emerging health care and information technology companies and management of professional organizations. Hodge was previously a general counsel at a publicly-traded technology company and practiced corporate and securities law for over twenty years.
David A. Jensen has more than 35 years of executive leadership experience. He previously served as President of Anthem, Blue Cross Blue Shield of Manchester, New Hampshire and President, CEO and Executive Director of American MedCenters, Inc.
Charles M. Linehan is a General Partner at New Enterprise Associates. He participated in the founding of Elder Health (now Bravo Health). Current board memberships include American Pathology Partners, Elance, Simplex Diabetic Supply, Subacute Holdings, Ulthera and Vantage Oncology.
David Ward is Co-Founder and General Partner of Salix Ventures, a national health care venture capital firm. Prior to starting Salix in 1997, Ward spent 15 years as a senior executive in several venture-backed health care companies.